ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_124248_7 # 6625 # 9738 # 1 # ID=86_7;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.537	k141_124248_7	6625	9738	+	Strict	750	776.933	adeF	42.17	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTTCAAAATTCTTCATAGACCGTCCTATCTTTGCTACCGTATTGGCGCTGCTCATCGTCGTAGCAGGACTGGTCACACTGGGCATCCTGCCCATTGCCCAATATCCGGACATCACACCACCCACCGTGCAGGTCAGTGCCGTATATCCCGGAGCCAATGCGCAGACGGTGGCACAAACCGTCGGCATCCCCATCGAGCAGCAAGTCAACGGAGTGGACGGAATGCTTTACATGTCCTCCAACTCCAGCTCATCGGGCGCTTACTCTCTTACCATTACTTTTGCCGTAGGCACAGACATTGATATGGCTACCGTGCAGGTCCAGAACCGGGTAAGCGTGGCCCAGTCGTCACTACCTACTCCCGTTGTGGTGCAAGGCGTCACTGTACAGAAACAGTCATCGAACATCGTGATGTTCCTCACGATGACGTCGGACAGCAAAGACTACGACGGACTTTACCTCAGCAACTATGCCAAGCTGAATCTCGTAGACCAGTTAACACGCGTGCCCGGTGTAGGCGCCGTCAATGTGATGGGAGCAGGGGACTACTCCATGCGTATCTGGCTCGACCCTGCCGCCATGCGCATCCGCTATCTTTCGCCGGCCGATGTATACCAAGCTATCCAATCACAGAATGTGGAGGTCAGCGCAGGTAACGTAGGGCAACCCATCGGCACAGACAATAAAAATGCCTATCAATACAGCCTGACCGTAAAAGGGCGCCTTACCTCACCCGAAGAGTTCGGCAACATTATCCTGCGTACCGAAACCGGAGGGAAGATACTCCGTCTGCGCGACGTGGCGCACATCGACCTAGGCTCGGCCTCTTACAGCGTAGTATCCCAACTGGACGGGAAACCCACCGCTGCCATCGCTATCTATCAGCAACCTGGCAGCAACTCGCTGGACGTTTCCAAAGGAGTAAAGGCAAAAATGCAGGAACTCTCGCAAAATTTCCCTGCAGGCATACAATACAATGTAACCCTGGACACTACGGATGTCATTCATGCTTCCATAGACGAAGTGATGGTGACGTTCCTTGAAACAACCCTGCTGGTAGTTCTCGTCATCTTCCTGTTCCTGCAGAACTGGCGGGTGGTCGTCATTCCCTGCATCACTATTCCGGTATCACTCATCGGCACACTGGCCGTCATGTCCTTGTTCGGCTTCTCCATCAATACGCTGACACTATTCGGACTGATACTTGCCGTGGCCATCGTGGTGGATGATGCCATTGTGGTGGTGGAGAACTCCACGCGTCTGCTGGACACGGGGCGCTACACCTCCCGCCAGACTGTGACCGAAGCGATGGGAGAGATTACCGGACCCATTGTCGGGGTAGTGCTGGTGCTGCTTGCCGTATTTATCCCGACAACACTCGTCAGCGGCATATCAGGACAACTGTATAAACAGTTTGCCTTGACCATTGCAGCCAGCACCGTACTTAGCGGATTCAACTCACTGACCCTTACTCCGGCACTCTGTGCCTTGATGCTGCAACCTACCCGGCCTTCCAAAAATCCCCTATATCGGGGGTTCAACCATCTGTACGACAAGACACAAGGAGTCTACGACCGGATAGTGGAGTACCTGCTCCAACGCCCTGTCGCTTCCATCGTTTCATATGCGGTTTTCACATTGATTGCTGTCCTGCTGTTTGTCAAATGGCCGTCCACATTTGTTCCGGAAGAAGATGACGGCTATTTCCTCGCAGTGGTACAGCTTCCCCCAGCATCGAGCCTGGAGCGCACCCAAGCCGTAGGAAAGCAGATAAACAAAATTCTCGATTCATACCCCGAAGTAAAGGACTACATCGGCATATCCGGCTTCTCCGTGATGGGAGGAGGGGAACAGAGCAATGCTGCCACCTACTTCATCGTGCTGAAGAACTGGAATGAACGCAAGGGAAAGAAACATACGGCTGAAGCCGTAGTGCAACGCTTCAATATGGAAGTGTACGGCATCCAGGAAGCAGAGATATTTGCCATGGTTCCACCTGCCATCCCCGGGCTGGGAGCCACCGGAGGCCTGCAACTCCACTTGGAAGACCGCCACAACCTCGGTGCCACCGAGATGCAACGTGCCGTAGAGACCTTGATGGAGCACTACCGCAATTATCCGGCATTGGCATCGGTCAGCAGCCAGTACCAGGCCAACGTACCGCAATATTTCCTAAATATCGACCGCGACAAGGTGCAACTGATGGGCATTCCGCTAAATAGCGTATTCACCGCCCTGGGCTACTATATGGGAGAGGCCTACGTCAATGATTATGTGCAGTTCGGCCACATCTACCAAGTGAAGCTGGGAGCAGGTGACCGTGCCCAGCGTGTCATCGACGATGTCCTGAAACTGAGCGTTCCCAATGCATCGGGCGAAATGGTACCTTTCTCTTCCTTCACCCGGGTGGAAGAACAGCTTGGCATGGACCAGATAAACCGCTACAACATGTACTCTACAGCAGCCGTGACCTGCAATGTGGCTCCGGGCAGTAGTTCGGGAGAGGGTATCCGGCAAATGGAAAGTCTAATCAAGGAGCATCTCGGAGACGAGTTCGGCTACGAATGGACTTCGGTAGCCTATCAGGAAACGCAGGCAGGAACCACTACGACCGTCGTATTCGTCATGGCGCTGCTGGTTGCCTTCCTTGTGCTCGCCGCACAATACGAAAGCTGGACTAGTCCGGTGGCCGCCGTAATGGGACTTCCGGTGGCGCTGCTCGGTGCCATGCTGGGATGCTATGTCATGGGTACTCCGGTCAGCATCTACACACAAATCGGCATCATCCTGCTGGTTGCCTTGTCTGCCAAAAACGGTATTCTGATTGTGGAGTTTGCACGTGACTTCCGTGCACAAGGCAATTCAATCCGTGATGCGGCATTCCAGGCAGGGCATATCCGTCTGCGGCCTATTCTGATGACATCGCTTGCATTCGTATTCGGGGTTATGCCGTTGCTTTTTGCCACCGGAGCAGGGGCGGGAAGCCGTATTGCACTGGGAGCTGCCGTAGTATTTGGTATGGCGCTGAACACATTGCTCGCCACGGTCTATATCCCGAATTTCTACGAATTGATGCAGAAGTTGCAGGAGAGGTTCAGTAAGAAACAATAG	MFSKFFIDRPIFATVLALLIVVAGLVTLGILPIAQYPDITPPTVQVSAVYPGANAQTVAQTVGIPIEQQVNGVDGMLYMSSNSSSSGAYSLTITFAVGTDIDMATVQVQNRVSVAQSSLPTPVVVQGVTVQKQSSNIVMFLTMTSDSKDYDGLYLSNYAKLNLVDQLTRVPGVGAVNVMGAGDYSMRIWLDPAAMRIRYLSPADVYQAIQSQNVEVSAGNVGQPIGTDNKNAYQYSLTVKGRLTSPEEFGNIILRTETGGKILRLRDVAHIDLGSASYSVVSQLDGKPTAAIAIYQQPGSNSLDVSKGVKAKMQELSQNFPAGIQYNVTLDTTDVIHASIDEVMVTFLETTLLVVLVIFLFLQNWRVVVIPCITIPVSLIGTLAVMSLFGFSINTLTLFGLILAVAIVVDDAIVVVENSTRLLDTGRYTSRQTVTEAMGEITGPIVGVVLVLLAVFIPTTLVSGISGQLYKQFALTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNPLYRGFNHLYDKTQGVYDRIVEYLLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQLPPASSLERTQAVGKQINKILDSYPEVKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKKHTAEAVVQRFNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLHLEDRHNLGATEMQRAVETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.92	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_124248_8 # 9876 # 10766 # 1 # ID=86_8;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.489	k141_124248_8	9876	10766	+	Strict	575	601.282	CblA-1	97.97	3002999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CblA beta-lactamase	ATGAAAGCATATTTCATCGCCATACTTACCTTATTCACTTGTATAGCTACCGTCGTCCGGGCGCAGCAAATGTCTGAACTTGAAAACCGGATTGACAGTCTGCTCAATGGCAAGAAAGCCACCGTTGGTATAGCCGTATGGACAGACAAAGGAGACATGCTCCGGTATAACGACCATGTACACTTCCCCTTGCTCAGTGTATTCAAATTCCATGTGGCACTGGCCGTACTGGACAAGATGGATAAGCAAAGCATCAGTCTGGACAGCATTGTTTCCATAAAGGCATCCCAAATGCTGCCCAATACCTACAGCCCCCTGCGGAAGAAGTTTCCCGACCAGGATTTCACGATTACGCTTAGGGAGCTGATGCAATACAGCATTTCCCAAAGCGACAACAATGCCTGCGACATCTTGATAGAATATGCAGGAGGTATCAAACATATCAATGACTATATCCGCCGGTTGGGTATCGACTCCTTCAACCTCTCGGAAACAGAAGACGACATGCACTCCAGCTTCGAGGCTGTATACCGCAACTGGAGTACTCCTTCCGCTATGGCCCGACTACTGAGAACGGCCGATGAAAAAGAGTTGTTCTCCAACAAGGAACTGAAAGACTTCTTGTGGCAGACCATGATAGATACTGAAACCGGTGCCAACAAACTGAAAGGTACGTTGCCAGCCAAAACCGTGGTAGGACACAAGACCGGCTCTTCCGACCGCAATGCCGACGGTATGAAAACTGCAGATAATGATGCCGGCCTCGTTATCCTTCCCGACGGCCGGAAATACTACATTGCCGCCTTCGTCATGGACTCATACGAGACGGATGAGGACAATGCGAACATCATCGCCCGCATATCACGCATGGTATATGATGCGATGAGATGA	MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGTLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR	MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR	100.00	gnl|BL_ORD_ID|0|hsp_num:0	2		
